Simvastatin vs atorvastatin
Pro Research Analysisby 
Searched over 200M research papers
Lipid-Lowering Efficacy: Simvastatin vs Atorvastatin
Several studies have compared the lipid-lowering effects of simvastatin and atorvastatin. Atorvastatin generally produces greater reductions in low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides compared to simvastatin at equivalent or even higher doses 2467. For example, atorvastatin 10 mg/day led to a 37.2% reduction in LDL cholesterol, compared to 29.6% with simvastatin 10 mg/day . In patients with familial hypercholesterolemia, atorvastatin also achieved greater reductions in LDL cholesterol and total cholesterol, and more patients reached target LDL levels 67.
HDL Cholesterol and Apolipoprotein A-I: Simvastatin’s Advantage
While atorvastatin is more effective at lowering LDL cholesterol, simvastatin has shown a greater ability to increase high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I, especially at higher doses 18. In head-to-head trials at maximal doses (80 mg), simvastatin increased HDL cholesterol and apo A-I more than atorvastatin, a difference observed across various patient subgroups, including those with metabolic syndrome 18.
Safety and Tolerability: Adverse Events and Liver Enzymes
Both statins are generally well tolerated, but some differences in side effects have been noted. At higher doses, atorvastatin is associated with a higher incidence of drug-related adverse events, particularly gastrointestinal symptoms and elevations in liver enzymes (alanine aminotransferase), compared to simvastatin 189. However, serious adverse events such as myopathy and rhabdomyolysis are rare for both drugs . In lower-dose studies, both statins had similar safety profiles, with most adverse events being mild to moderate 24.
Achieving Cholesterol Targets: Clinical Effectiveness
Atorvastatin is more likely to help patients reach LDL cholesterol targets, especially in those with severe hyperlipidemia or familial hypercholesterolemia 467. In one study, 55.6% of patients on atorvastatin 10 mg/day reached LDL goals, compared to 38.4% on simvastatin 10 mg/day . However, in a smaller study comparing simvastatin 10 mg and atorvastatin 20 mg, no significant difference in clinical effectiveness was found, possibly due to limited sample size .
Cardiovascular Outcomes: Secondary Prevention
In patients with a history of myocardial infarction, high-dose atorvastatin (80 mg) reduced the risk of nonfatal acute myocardial infarction and other composite cardiovascular events more than usual-dose simvastatin (20 mg), although there was no significant difference in overall mortality between the two groups .
Other Effects: Depression and Psychological Outcomes
A small study in post-coronary artery bypass graft patients with depression found that simvastatin may have superior antidepressant effects compared to atorvastatin, though both were well tolerated and no serious adverse events were reported .
Conclusion
Atorvastatin is generally more effective than simvastatin at lowering LDL cholesterol, total cholesterol, and triglycerides, and is more likely to help patients reach cholesterol targets, especially in high-risk populations. Simvastatin, particularly at higher doses, is more effective at raising HDL cholesterol and apolipoprotein A-I. Both drugs are well tolerated, but atorvastatin at high doses may cause more gastrointestinal symptoms and liver enzyme elevations. The choice between these statins should consider individual patient lipid profiles, risk factors, and tolerance.
Sources and full results
Most relevant research papers on this topic